No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk
BofA Securities Lowers Bruker Price Target to $61 From $76
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $50
Barclays Remains a Buy on Bruker (BRKR)
Why Is Life Science Focused Bruker Stock Trading Higher On Friday?
Bruker Shares Are Trading Higher After the Company Issued Q1 Revenue Guidance Above Consensus Estimates and Announced a Partnership With Ridom for NGS Bioinformatic Applications.